“Our study reveals some very interesting clinical insights, particularly around the short incubation period of the virus, extremely high viral shedding from the nose, as well as the utility of lateral flow tests, with potential implications for public health.
Clinical insightsIn the trial, 36 healthy male and female volunteers aged 18-30 years, unvaccinated against COVID-19 and with no prior infection with SARS-CoV-2 were given a low dose of the virus – introduced via drops up the nose – and then carefully monitored by clinical staff in a controlled environment over a two-week period.”
https://www.imperial.ac.uk/news/233514/covid-19-human-challenge-study-reveals-detailed/
Where’s the ethics committee ? - Nose is the source.
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.5¢ |
Change
0.005(4.17%) |
Mkt cap ! $51.50M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 12.5¢ | 11.5¢ | $9.147K | 76.19K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 532267 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 12500 | 1 |
View Market Depth
| Last trade - 15.42pm 06/05/2024 (20 minute delay) ? |
| SPL (ASX) Chart |